SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PROTEOMICS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject10/30/2003 12:41:55 PM
From: tuck  Read Replies (1) of 539
 
[Protein knockout (as opposed to mere knockdown)]

>>Published online before print October 30, 2003
Proc. Natl. Acad. Sci. USA, 10.1073/pnas.2233012100

Genetics
Exploring the functional complexity of cellular proteins by protein knockout

Jianxuan Zhang *, Ning Zheng , and Pengbo Zhou *
*Department of Pathology and Laboratory Medicine, Graduate Program in Molecular Biology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021; and Department of Pharmacology, University of Washington, Seattle, WA 98195

Edited by Mark Ptashne, Memorial Sloan-Kettering Cancer Center, New York, NY, and approved September 3, 2003 (received for review May 19, 2003)

Comprehensive dissection of protein functions entails more complicated manipulations than simply eliminating the protein of interest. Established knockdown technologies, such as RNA interference, antisense oligodeoxynucleotides, or ribozymes, are limited for specific applications such as modulating protein levels or specific targeting of a posttranslationally modified subpopulation. Here we show that the engineered Skp1, Cullin 1, and F-box-containing TrCP substrate receptor ubiquitin-proteolytic system, designated protein knockout, could achieve not only total elimination but also rapid and systematic reduction of a given cellular protein. Stable expression of a single engineered TrCP demonstrated simultaneous and sustained degradation of the entire retinoblastoma family proteins. Furthermore, the engineered TrCP was capable of selecting hypo- but not hyperphosphorylated forms of retinoblastoma for degradation. The engineered TrCP has been extensively modified to increase its specificity in substrate selection. This optimized protein-knockout system offers a powerful and versatile proteomic tool to dissect diverse functional properties of cellular proteins in somatic cells.<<

Worth watching this technology, IMO.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext